Oral PCSK9 inhibitor significantly lowers LDL-C Presented ByProf. Christie Ballantyne, Baylor College of Medicine, TX, USA TrialPhase 2 ConferenceACC 2023 TypePeer-reviewed article 7 June 2023 09:30
Novel oral PCSK9 inhibitor shows promising results for hypercholesterolaemia Presented ByDr Douglas Johns ConferenceAHA 2021 TypePeer-reviewed article 14 January 2022 14:16